Rare diseases
Investigational molecules
Locations
Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
CroatiaStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
CroatiaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CroatiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
CroatiaStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
CroatiaStudy on Fenebrutinib for Patients with Relapsing Multiple Sclerosis
CroatiaStudy Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
CroatiaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections
CroatiaStudy on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy
CroatiaStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
CroatiaStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
CroatiaStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
CroatiaTell us about your condition – we search every trial in Europe and connect you with the right site.
